Anterix Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $7M+16.7% YoYTTM through 30 Jun 2026
Net Income $65.7MTTM through 30 Jun 2026
Free Cash Flow $10.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | 1,444.9% |
| Net Margin | 933.0% |
Returns
34.6%ROE
19.5%ROA
34.6%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio4.85x
Net Debt-$98.5Mnet cash position
Cash & Equivalents$116M
Quality Metrics
Altman Z-Score4.66
Piotroski F-Score5 / 9
FCF Margin151.0%
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2026: $6.5M
Diluted EPS$3.49TTMFY2026: $4.83
Dividend
No dividend
Capital Allocation
R&D Spend$4.8M
Capex Intensity1.0%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Spectrum Commercialization | $6.5M | +7.8% | View detailsAnterix expects contracted customer cash proceeds of $25.3 million in fiscal 2027 and $23.4 million thereafter. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.